IncFact
Company Profiles: Revenue, Growth, Competition

Gilead Sciences Revenue, Growth & Competitor Profile

DBA GILEAD
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Gilead Sciences

Access the complete profile.

Gilead Sciences Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
5417 Scientific Research & Development Services
Address333 Lakeside Drive
Foster City, CA 94404



Gilead Sciences's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Gilead Sciences is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Gilead Sciences is a publicly traded company on NMS using the ticker symbol GILD. Detailed information on company financials and operating reports can be found here: NMS: GILD



Gilead Sciences Annual Revenue and Growth Rate

Gilead Sciences Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Over $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Gilead Sciences's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Gilead Sciences is developing and marketing. Gilead Sciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ZERO HOUR
Downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, and medical conditions
03/16/2023
HELPING TO BRING MORE LIFE TO PEOPLE WITH CANCER
Promoting public awareness in the field of oncology, namely, medical and scientific research, treatment, diagnosis and patient and family services
02/07/2023
CREATING POSSIBLE FUND
charitable services, namely, providing financial grants to individuals, organizations and programs in support of improving health, well-being and social justice; philanthropic services concerning monetary donations
09/14/2022

See all trademarks and details in the Full Report.


Market Share of Gilead Sciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Gilead Sciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Gilead Sciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
GILEAD SCIENCESFoster City, CA100 
SCICLONE PHARMACEUTICALSSan Mateo, CA1 
DOMPE U.S.San Mateo, CA1 
FORTY SEVENSan Mateo, CA0 
REVIR THERAPEUTICSFoster City, CA0 
MICURX PHARMACEUTICALSFoster City, CA0 




Future Competition: Gilead Sciences's Fastest Growing Competitors

These companies are in the same general field as Gilead Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Gilead Sciences Competitors